Pivotal Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema (DIAMOND-1) (clinicaltrials.gov) - Jul 11, 2024 - P2/3 | N=497 | Recruiting | Sponsor: Oculis | Active, not recruiting ➔ Recruiting | Trial completion date: Aug 2025 ➔ Jun 2026 | Trial primary completion date: Jun 2025 ➔ Jun 2026
Enrollment open • Trial completion date • Trial primary completion date • Diabetic Macular Edema • Ophthalmology
|